reac-technology
Contact us
reac-technology
Contact us
Radio Electric Asymmetrically Conveyed Fields

Precision Neuromodulation Protocols

A sophisticated, non-invasive therapy to rebalance and enhance nervous system activity.
Our proprietary REAC® Technology precisely modulates endogenous bioelectric fields,
fostering improved adaptation, resilience, and overall wellbeing.
ask for more details
Application areas

Neurobiological Modulation based on REAC® Technology

neuromodulation-reac

The biggest issue

Chronic stress may induce nervous system maladaptation. This dysfunctional state has been linked to a broad spectrum of conditions across various medical fields, such as chronic pain, anxiety, fatigue, sleep disorders, psychosomatic conditions, hyperactivity, and impaired mental health.
Behavioral and Mood Disorders
Specialized REAC® protocols modulate weak, asymmetric radiofrequency fields. They interact with endogenous bioelectrical activity to optimize neural circuits regulating mood & behavior, restoring neuro-biophysical balance.
Pain Syndromes
For pain syndromes, REAC® treatments modulate endogenous bioelectricity. This optimizes neural processing of pain signals, reducing the perception of pain.
Postural and Motor Disorders
For postural & motor disorders, REAC® treatments modulate endogenous bioelectricity via weak radiofields, optimizing neural circuits & neuromuscular communication for improved balance, coordination, and motor control.
Stress-Related Disorders
For stress disorders, REAC® treatments optimize the body's adaptive response. Weak radiofields modulate endogenous bioelectricity, normalizing neuro-biophysical function altered by stressors & improving coping mechanisms.
Mental Health
For mental health, REAC® technology modulates endogenous bioelectricity with weak radiofields. It targets optimization of neural circuits governing mood, cognition, & stress, improving overall neuro-biophysical function.
Prevention
Treatments based on REAC® technology, in addition to acting on targeted objectives, contribute to prevention by promoting functional adaptive neurobiological responses, reducing chronic stress and supporting mental and physical resilience over time.

Therapeutic Protocols Explore

Would you like to learn more about the specific neuromodulation protocols based on REAC® Technology?
ask for it
reac-technology
Effective, Safe, Painless, Non-invasive

REAC® Technology, developed by the Rinaldi Fontani Institute and powered by ASMED

European-Flag

European Union

brasilian-flag

Brazil

Privacy*
reac-technology
Home About News
Contact us
© 2026 REAC® All rights reserved
Privacy Policy Terms of Use and Legal Notice
Manage Cookie Credits

Dr. Vania Fontani

dr-vania-fontani-rinaldi-fontani-institute

Dr. Vania Fontani MD, PhD, is a prominent figure in the field of regenerative medicine and neurobiological modulation.

She has dedicated her career to research and the development of innovative technologies for human well-being.

Currently, Dr. Fontani holds the position of Scientific Director at the Rinaldi Fontani Institute in Florence, where she leads the Department of Regenerative Medicine.

In collaboration with Prof. Salvatore Rinaldi, she co-developed the REAC® (Radio Electric Asymmetric Conveyer) technology, a non-invasive methodology aimed at modulating endogenous bioelectric activity to promote health and well-being.

Her research work is documented in over 60 scientific publications, with a significant impact in the field of neuromodulation and regenerative medicine.
Her experience and expertise make her an ideal speaker for international events focused on innovation and longevity

Learn more:
• Publications: PubMed – Rinaldi S, Fontani V

Prof. Salvatore Rinaldi

dr-salvatore-rinaldi-rinaldi-fontani-institu

Physician and researcher, pioneer in neurobiological modulation, regenerative medicine, and anti-senescence therapies Scientific Director – Rinaldi Fontani Institute, Florence, Italy
ORCID: 0000-0002-8961-6316

Profile and Mission

Salvatore Rinaldi is an internationally recognized innovator for his groundbreaking
contribution to the study and clinical application of neurobiological modulation using
asymmetrically conveyed radio-electric signals (REAC). His work has redefined the
boundaries of regenerative medicine and longevity, demonstrating how optimizing
endogenous bioelectrical activity can promote cellular reprogramming, recovery of
compromised functions, and the prevention of age-related decline.

 

Research Milestones

Rinaldi’s research has opened new frontiers in the understanding and treatment of
neurodegenerative diseases and cellular aging processes. Among his most significant
contributions:


Regenerative Medicine:

  • Direct cellular reprogramming through epigenetic modulation of
    endogenous bioelectrical activity with REAC technology.
  • Radiofrequency energy loop primes cardiac, neuronal, and skeletal muscle
    differentiation in mouse embryonic stem cells: a new tool for improving tissue
    regeneration. Cell Transplant. 2012;21(6):1225-33. doi: 10.3727/096368911X600966.
  • Radio electric conveyed fields directly reprogram human dermal skin fibroblasts
    toward cardiac, neuronal, and skeletal muscle-like lineages. Cell Transplant.
    2013;22(7):1227-35. doi: 10.3727/096368912X657297.
  • Neurological morphofunctional differentiation induced by REAC technology in PC12. A
    neuro protective model for Parkinson's disease. Sci Rep. 2015 May 15:5:10439. doi:
    10.1038/srep10439.

Anti-Senescence and Longevity:

  • REAC technology and hyaluron synthase 2, an interesting network to slow down stem
    cell senescence. Sci Rep. 2016 Jun 24:6:28682. doi: 10.1038/srep28682.
  • Stem cell senescence. Effects of REAC technology on telomerase-independent and
    telomerase-dependent pathways. Sci Rep. 2014 Sep 16:4:6373. doi:
    10.1038/srep06373.
  • Anti-senescence efficacy of radio-electric asymmetric conveyer technology. Age
    (Dordr). 2014 Feb;36(1):9-20. doi: 10.1007/s11357-013-9537-8.

Neurodegenerative Diseases – Efficacy of REAC Technology in Alzheimer’s and
Neurodegeneration Models:

  • REAC technology modifies pathological neuroinflammation and motor behaviour in an
    Alzheimer's disease mouse model. Sci Rep. 2016 Oct 24:6:35719. doi:
    10.1038/srep35719.
  • Radio Electric Asymmetric Conveyer Technology Modulates Neuroinflammation in a
    Mouse Model of Neurodegeneration. Neurosci Bull. 2018 Apr;34(2):270-282. doi:
    10.1007/s12264-017-0188-0

Scientific Vision

Salvatore Rinaldi’s work demonstrates that bioelectrical modulation is not merely a
theoretical concept, but a concrete and reproducible therapeutic strategy to counteract
aging, support cellular repair processes, and prevent tissue degeneration.

Learn more:
• ORCID Profile: 0000-0002-8961-6316
• Publications: PubMed – Rinaldi S, Fontani V